{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:08:50Z","timestamp":1793146130942,"version":"4.5.0"},"reference-count":165,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-024-02426-0","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T03:24:07Z","timestamp":1736738647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Yanyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"2","key":"2426_CR1","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197\u2013206.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"2426_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic Cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10\u201327.","journal-title":"World J Oncol"},{"issue":"8","key":"2426_CR3","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4251\/wjgo.v14.i8.1456","volume":"14","author":"C-Y Zhang","year":"2022","unstructured":"Zhang C-Y, Liu S, Yang M. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World J Gastrointest Oncol. 2022;14(8):1456\u201368.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"2426_CR4","first-page":"35","volume":"11","author":"XB Zhang","year":"2024","unstructured":"Zhang XB, et al. Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives. Mil Med Res. 2024;11(1):35.","journal-title":"Mil Med Res"},{"key":"2426_CR5","doi-asserted-by":"crossref","unstructured":"Wood LD et al. Pancreatic Cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology, 2022. 163(2).","DOI":"10.1053\/j.gastro.2022.03.056"},{"key":"2426_CR6","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.canep.2021.102068","volume":"76","author":"Z Shi","year":"2022","unstructured":"Shi Z, et al. Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030. Cancer Epidemiol. 2022;76:102068.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"2426_CR7","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells. Oncogenesis. 2016;5(1):e189.","journal-title":"Oncogenesis"},{"key":"2426_CR8","doi-asserted-by":"crossref","unstructured":"Bian X et al. Lipid metabolism and cancer. J Exp Med, 2021. 218(1).","DOI":"10.1084\/jem.20201606"},{"key":"2426_CR9","doi-asserted-by":"crossref","unstructured":"Sunami Y, Rebelo A, Kleeff J. Lipid metabolism and lipid droplets in pancreatic Cancer and stellate cells. Cancers (Basel), 2017. 10(1).","DOI":"10.3390\/cancers10010003"},{"issue":"12","key":"2426_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cac2.12360","volume":"42","author":"X Yin","year":"2022","unstructured":"Yin X, et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (Lond). 2022;42(12):1234\u201356.","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"2426_CR11","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"15","key":"2426_CR12","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1158\/0008-5472.CAN-11-4112","volume":"72","author":"N Zaidi","year":"2012","unstructured":"Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res. 2012;72(15):3709\u201314.","journal-title":"Cancer Res"},{"issue":"12","key":"2426_CR13","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","volume":"66","author":"FP Kuhajda","year":"2006","unstructured":"Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66(12):5977\u201380.","journal-title":"Cancer Res"},{"key":"2426_CR14","doi-asserted-by":"crossref","unstructured":"Daya T et al. Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies. Biochim Biophys Acta Mol Cell Biol Lipids, 2024: p. 159578.","DOI":"10.1016\/j.bbalip.2024.159578"},{"key":"2426_CR15","doi-asserted-by":"publisher","first-page":"928821","DOI":"10.3389\/fphar.2023.928821","volume":"14","author":"W Xia","year":"2023","unstructured":"Xia W, et al. The role of cholesterol metabolism in tumor therapy, from bench to bed. Front Pharmacol. 2023;14:928821.","journal-title":"Front Pharmacol"},{"key":"2426_CR16","doi-asserted-by":"crossref","unstructured":"Vassiliou E, Farias-Pereira R. Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity. Int J Mol Sci, 2023. 24(15).","DOI":"10.3390\/ijms241512032"},{"issue":"4","key":"2426_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.6052","volume":"259","author":"K Cao","year":"2023","unstructured":"Cao K, et al. Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia. J Pathol. 2023;259(4):388\u2013401.","journal-title":"J Pathol"},{"issue":"7","key":"2426_CR18","doi-asserted-by":"publisher","first-page":"e2202956","DOI":"10.1002\/advs.202202956","volume":"10","author":"J Li","year":"2023","unstructured":"Li J, et al. Tumor Cell-intrinsic CD96 mediates Chemoresistance and Cancer Stemness by regulating mitochondrial fatty acid \u03b2-Oxidation. Adv Sci (Weinh). 2023;10(7):e2202956.","journal-title":"Adv Sci (Weinh)"},{"key":"2426_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","volume":"435","author":"Y Ma","year":"2018","unstructured":"Ma Y, et al. Fatty acid oxidation: an emerging facet of metabolic transformation in cancer. Cancer Lett. 2018;435:92\u2013100.","journal-title":"Cancer Lett"},{"issue":"1","key":"2426_CR20","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41467-021-25354-4","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu W, et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. Nat Commun. 2021;12(1):5103.","journal-title":"Nat Commun"},{"key":"2426_CR21","doi-asserted-by":"crossref","unstructured":"Tanase C et al. CD36 and CD97 in pancreatic Cancer versus other malignancies. Int J Mol Sci, 2020. 21(16).","DOI":"10.3390\/ijms21165656"},{"issue":"2","key":"2426_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2017.01.016","volume":"25","author":"Z Li","year":"2017","unstructured":"Li Z, Kang Y. Lipid metabolism Fuels Cancer\u2019s spread. Cell Metab. 2017;25(2):228\u201330.","journal-title":"Cell Metab"},{"issue":"9","key":"2426_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100(9):1369\u201372.","journal-title":"Br J Cancer"},{"issue":"5","key":"2426_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","volume":"13","author":"Q Du","year":"2022","unstructured":"Du Q, et al. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death Dis. 2022;13(5):488.","journal-title":"Cell Death Dis"},{"key":"2426_CR25","doi-asserted-by":"crossref","unstructured":"Maier T, Jenni S, Ban N. Architecture of mammalian fatty acid synthase at 4.5 A resolution. Science (New York, N.Y.), 2006. 311(5765): pp. 1258\u20131262.","DOI":"10.1126\/science.1123248"},{"issue":"20","key":"2426_CR26","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1158\/0008-5472.CAN-16-3062","volume":"77","author":"S Tadros","year":"2017","unstructured":"Tadros S, et al. De Novo lipid synthesis facilitates Gemcitabine Resistance through endoplasmic reticulum stress in pancreatic Cancer. Cancer Res. 2017;77(20):5503\u201317.","journal-title":"Cancer Res"},{"issue":"16","key":"2426_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.21037\/atm-22-3685","volume":"10","author":"H Zhu","year":"2022","unstructured":"Zhu H, et al. MiR-195-5p suppresses the proliferation, migration, and invasion of gallbladder cancer cells by targeting FOSL1 and regulating the Wnt\/\u03b2-catenin pathway. Ann Transl Med. 2022;10(16):893.","journal-title":"Ann Transl Med"},{"issue":"1","key":"2426_CR28","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1515\/med-2022-0441","volume":"17","author":"T Sun","year":"2022","unstructured":"Sun T, et al. Decreased expression of miR-195 mediated by hypermethylation promotes osteosarcoma. Open Med (Wars). 2022;17(1):441\u201352.","journal-title":"Open Med (Wars)"},{"issue":"7","key":"2426_CR29","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/ijc.32042","volume":"144","author":"C Vernieri","year":"2019","unstructured":"Vernieri C, et al. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs). Int J Cancer. 2019;144(7):1704\u201312.","journal-title":"Int J Cancer"},{"issue":"12","key":"2426_CR30","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.4158\/EP-2020-0347","volume":"26","author":"DS Schade","year":"2020","unstructured":"Schade DS, Shey L, Eaton RP. Cholesterol review: a metabolically important molecule. Endocr Pract. 2020;26(12):1514\u201323.","journal-title":"Endocr Pract"},{"issue":"2","key":"2426_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song B-L, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metabolism. 2020;2(2):132\u201341.","journal-title":"Nat Metabolism"},{"key":"2426_CR32","doi-asserted-by":"publisher","first-page":"216208","DOI":"10.1016\/j.canlet.2023.216208","volume":"564","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. Cancer Lett. 2023;564:216208.","journal-title":"Cancer Lett"},{"issue":"5","key":"2426_CR33","first-page":"709","volume":"45","author":"J Gu","year":"2022","unstructured":"Gu J, et al. Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor. Cell Oncol (Dordrecht Netherlands). 2022;45(5):709\u201328.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"issue":"1","key":"2426_CR34","doi-asserted-by":"publisher","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","volume":"1874","author":"H Xu","year":"2020","unstructured":"Xu H, et al. Cholesterol metabolism: new functions and therapeutic approaches in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874(1):188394.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"28","key":"2426_CR35","first-page":"e2200750","volume":"9","author":"S Zheng","year":"2022","unstructured":"Zheng S, et al. Aberrant cholesterol metabolism and Wnt\/\u03b2-Catenin signaling Coalesce via Frizzled5 in supporting Cancer Growth. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2022;9(28):e2200750.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"1","key":"2426_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/pancan.2021.0002","volume":"7","author":"JI Alexander","year":"2021","unstructured":"Alexander JI, et al. Cholesterol and CDON regulate sonic hedgehog release from pancreatic Cancer cells. J Pancreat Cancer. 2021;7(1):39\u201347.","journal-title":"J Pancreat Cancer"},{"issue":"8","key":"2426_CR37","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1073\/pnas.1421601112","volume":"112","author":"F Guillaumond","year":"2015","unstructured":"Guillaumond F, et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Proc Natl Acad Sci U S A. 2015;112(8):2473\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2426_CR38","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1158\/2159-8290.CD-18-0567","volume":"9","author":"A Carrer","year":"2019","unstructured":"Carrer A, et al. Acetyl-CoA metabolism supports multistep pancreatic tumorigenesis. Cancer Discov. 2019;9(3):416\u201335.","journal-title":"Cancer Discov"},{"issue":"8","key":"2426_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41419-023-05987-7","volume":"14","author":"R Xu","year":"2023","unstructured":"Xu R, et al. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src\/PI3K\/Akt signaling pathway. Cell Death Dis. 2023;14(8):497.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2426_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12013-022-01081-5","volume":"80","author":"AD Dergunov","year":"2022","unstructured":"Dergunov AD, Baserova VB. Different pathways of Cellular Cholesterol Efflux. Cell Biochem Biophys. 2022;80(3):471\u201381.","journal-title":"Cell Biochem Biophys"},{"issue":"10","key":"2426_CR41","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA. HDL and Reverse Cholesterol Transport. Circul Res. 2019;124(10):1505\u201318.","journal-title":"Circul Res"},{"key":"2426_CR42","doi-asserted-by":"publisher","first-page":"105377","DOI":"10.1016\/j.jsbmb.2019.105377","volume":"191","author":"B Sharma","year":"2019","unstructured":"Sharma B, Agnihotri N. Role of cholesterol homeostasis and its efflux pathways in cancer progression. J Steroid Biochem Mol Biol. 2019;191:105377.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2426_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semcancer.2020.11.002","volume":"73","author":"SC Delk","year":"2021","unstructured":"Delk SC, et al. Apolipoprotein mimetics in cancer. Semin Cancer Biol. 2021;73:158\u201368.","journal-title":"Semin Cancer Biol"},{"key":"2426_CR44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcancer.2020.11.012","volume":"73","author":"G Revilla","year":"2021","unstructured":"Revilla G, et al. LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies. Semin Cancer Biol. 2021;73:134\u201357.","journal-title":"Semin Cancer Biol"},{"issue":"17","key":"2426_CR45","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.7150\/jca.60340","volume":"12","author":"F Wang","year":"2021","unstructured":"Wang F, et al. Dyslipidemia in Chinese Pancreatic Cancer patients: a two-Center Retrospective Study. J Cancer. 2021;12(17):5338\u201344.","journal-title":"J Cancer"},{"key":"2426_CR46","doi-asserted-by":"crossref","unstructured":"Huang W et al. The dual-targeted peptide conjugated probe for depicting residual nasopharyngeal carcinoma and guiding surgery. Biosens (Basel), 2022. 12(9).","DOI":"10.3390\/bios12090729"},{"key":"2426_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2020.08.045","volume":"495","author":"RC Smith","year":"2020","unstructured":"Smith RC, et al. Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice. Cancer Lett. 2020;495:112\u201322.","journal-title":"Cancer Lett"},{"issue":"3","key":"2426_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"SH Moon","year":"2019","unstructured":"Moon SH, et al. p53 represses the Mevalonate pathway to Mediate Tumor suppression. Cell. 2019;176(3):564\u2013e58019.","journal-title":"Cell"},{"issue":"1","key":"2426_CR49","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41467-021-24315-1","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, et al. Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness. Nat Commun. 2021;12(1):4230.","journal-title":"Nat Commun"},{"issue":"4","key":"2426_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893323040143","volume":"57","author":"IA Pobozheva","year":"2023","unstructured":"Pobozheva IA, et al. [AdipoRon Effect on expression of lipid metabolism genes in cultured human primary macrophages]. Mol Biol (Mosk). 2023;57(4):623\u201331.","journal-title":"Mol Biol (Mosk)"},{"issue":"1","key":"2426_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s11658-022-00348-2","volume":"27","author":"M Vaghari-Tabari","year":"2022","unstructured":"Vaghari-Tabari M, et al. CRISPR\/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. Cell Mol Biol Lett. 2022;27(1):49.","journal-title":"Cell Mol Biol Lett"},{"issue":"22","key":"2426_CR52","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1158\/0008-5472.CAN-20-1255","volume":"80","author":"CN Rozeveld","year":"2020","unstructured":"Rozeveld CN, et al. KRAS controls Pancreatic Cancer cell lipid metabolism and invasive potential through the lipase HSL. Cancer Res. 2020;80(22):4932\u201345.","journal-title":"Cancer Res"},{"issue":"11","key":"2426_CR53","first-page":"1","volume":"51","author":"JH Lee","year":"2019","unstructured":"Lee JH, et al. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism. Exp Mol Med. 2019;51(11):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2426_CR54","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gutjnl-2018-317581","volume":"69","author":"L Che","year":"2020","unstructured":"Che L, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69(1):177\u201386.","journal-title":"Gut"},{"key":"2426_CR55","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/OTT.S287722","volume":"14","author":"A Han","year":"2021","unstructured":"Han A, et al. HSDL2 acts as a promoter in pancreatic Cancer by regulating cell proliferation and lipid metabolism. Onco Targets Ther. 2021;14:435\u201344.","journal-title":"Onco Targets Ther"},{"issue":"3","key":"2426_CR56","doi-asserted-by":"publisher","first-page":"e0214294","DOI":"10.1371\/journal.pone.0214294","volume":"14","author":"L Mouhid","year":"2019","unstructured":"Mouhid L, et al. Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer. PLoS ONE. 2019;14(3):e0214294.","journal-title":"PLoS ONE"},{"issue":"1","key":"2426_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-023-02611-6","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Integrated multi-dimensional analysis highlights DHCR7 mutations involving in cholesterol biosynthesis and contributing therapy of gastric cancer. J Exp Clin Cancer Res. 2023;42(1):36.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2426_CR58","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/1541-7786.MCR-23-0199","volume":"22","author":"R Desai","year":"2024","unstructured":"Desai R, et al. Oncogenic GNAS uses PKA-Dependent and independent mechanisms to induce cell proliferation in human pancreatic ductal and Acinar Organoids. Mol Cancer Res. 2024;22(5):440\u201351.","journal-title":"Mol Cancer Res"},{"key":"2426_CR59","doi-asserted-by":"crossref","unstructured":"Cai Z et al. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming. Oncol Rep, 2023. 50(1).","DOI":"10.3892\/or.2023.8578"},{"key":"2426_CR60","doi-asserted-by":"crossref","unstructured":"Zhang M et al. PLA2G2A phospholipase promotes fatty acid synthesis and energy metabolism in pancreatic Cancer cells with K-ras mutation. Int J Mol Sci, 2022. 23(19).","DOI":"10.3390\/ijms231911721"},{"issue":"1","key":"2426_CR61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/hep.32112","volume":"75","author":"CD Fuchs","year":"2022","unstructured":"Fuchs CD, et al. Hepatocyte-specific deletion of adipose triglyceride lipase (adipose triglyceride lipase\/patatin-like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. Hepatology. 2022;75(1):125\u201339.","journal-title":"Hepatology"},{"issue":"3","key":"2426_CR62","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","volume":"41","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee A, Bilecz AJ, Lengyel E. The adipocyte microenvironment and cancer. Cancer Metastasis Rev. 2022;41(3):575\u201387.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"2426_CR63","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/jmf.2022.K.0061","volume":"26","author":"HY Kim","year":"2023","unstructured":"Kim HY, Moon JY, Cho SK. Heptadecanoic Acid, an odd-chain fatty acid, induces apoptosis and enhances Gemcitabine Chemosensitivity in Pancreatic Cancer cells. J Med Food. 2023;26(3):201\u201310.","journal-title":"J Med Food"},{"issue":"11","key":"2426_CR64","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","volume":"34","author":"M Martin-Perez","year":"2022","unstructured":"Martin-Perez M, et al. The role of lipids in cancer progression and metastasis. Cell Metab. 2022;34(11):1675\u201399.","journal-title":"Cell Metab"},{"key":"2426_CR65","doi-asserted-by":"publisher","first-page":"577420","DOI":"10.3389\/fonc.2020.577420","volume":"10","author":"LP Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez LP, G\u00f3mez M, de Cedr\u00f3n. Ram\u00edrez De Molina, alterations of lipid metabolism in Cancer: implications in prognosis and treatment. Front Oncol. 2020;10:577420.","journal-title":"Front Oncol"},{"issue":"2","key":"2426_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat Rev Clin Oncol. 2021;18(2):85\u2013100.","journal-title":"Nat Rev Clin Oncol"},{"key":"2426_CR67","doi-asserted-by":"crossref","unstructured":"Masetti M et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med, 2022. 219(2).","DOI":"10.1084\/jem.20210564"},{"key":"2426_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/164_2019_216","volume":"259","author":"J Gomez-Cambronero","year":"2020","unstructured":"Gomez-Cambronero J, Shah KN. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: inhibitors of PLD at the crossroads of Phospholipid Biology and Cancer. Handb Exp Pharmacol. 2020;259:89\u2013113.","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"2426_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.31083\/j.fbl2801010","volume":"28","author":"Q He","year":"2023","unstructured":"He Q, et al. Cellular Uptake, metabolism and sensing of long-chain fatty acids. Front Biosci (Landmark Ed). 2023;28(1):10.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2426_CR70","doi-asserted-by":"publisher","first-page":"p8879227","DOI":"10.1155\/2021\/8879227","volume":"2021","author":"Y Fu","year":"2021","unstructured":"Fu Y, et al. Associations among Dietary Omega-3 polyunsaturated fatty acids, the gut microbiota, and intestinal immunity. Mediators Inflamm. 2021;2021:p8879227.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"2426_CR71","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41366-024-01478-7","volume":"48","author":"F Wang","year":"2024","unstructured":"Wang F, et al. The endoplasmic reticulum stress protein GRP94 modulates cathepsin L activity in M2 macrophages in conditions of obesity-associated inflammation and contributes to their pro-inflammatory profile. Int J Obes (Lond). 2024;48(6):830\u201340.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"2426_CR72","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","volume":"4","author":"P Altea-Manzano","year":"2023","unstructured":"Altea-Manzano P, et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03baB signaling. Nat Cancer. 2023;4(3):344\u201364.","journal-title":"Nat Cancer"},{"key":"2426_CR73","doi-asserted-by":"publisher","first-page":"850066","DOI":"10.3389\/fphar.2022.850066","volume":"13","author":"R Abdel-Latif","year":"2022","unstructured":"Abdel-Latif R, et al. TLRs-JNK\/ NF-\u03baB pathway underlies the Protective Effect of the Sulfide Salt Against Liver toxicity. Front Pharmacol. 2022;13:850066.","journal-title":"Front Pharmacol"},{"issue":"18","key":"2426_CR74","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1007\/s00253-023-12694-y","volume":"107","author":"J Li","year":"2023","unstructured":"Li J, et al. Functions and substrate selectivity of diacylglycerol acyltransferases from Mortierella Alpina. Appl Microbiol Biotechnol. 2023;107(18):5761\u201374.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"43","key":"2426_CR75","doi-asserted-by":"publisher","first-page":"98127","DOI":"10.1007\/s11356-023-29397-6","volume":"30","author":"X Wang","year":"2023","unstructured":"Wang X, et al. Toxic effects of copper on duck cerebrum: a crucial role of oxidative stress and endoplasmic reticulum quality control. Environ Sci Pollut Res Int. 2023;30(43):98127\u201338.","journal-title":"Environ Sci Pollut Res Int"},{"key":"2426_CR76","doi-asserted-by":"crossref","unstructured":"Djuricic I, Calder PC. Beneficial outcomes of Omega-6 and Omega-3 polyunsaturated fatty acids on Human Health: an update for 2021. Nutrients, 2021. 13(7).","DOI":"10.3390\/nu13072421"},{"key":"2426_CR77","doi-asserted-by":"crossref","unstructured":"Das UN. Infection, inflammation, and immunity in Sepsis. Biomolecules, 2023. 13(9).","DOI":"10.3390\/biom13091332"},{"issue":"15","key":"2426_CR78","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1111\/j.1742-4658.2012.08644.x","volume":"279","author":"CR Santos","year":"2012","unstructured":"Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279(15):2610\u201323.","journal-title":"FEBS J"},{"key":"2426_CR79","doi-asserted-by":"crossref","unstructured":"Zimta AA et al. Molecular links between Central Obesity and breast Cancer. Int J Mol Sci, 2019. 20(21).","DOI":"10.3390\/ijms20215364"},{"key":"2426_CR80","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3389\/fimmu.2018.01229","volume":"9","author":"K Kaur","year":"2018","unstructured":"Kaur K, et al. Deficiencies in natural killer cell numbers, expansion, and function at the Pre-neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the pancreas of obese mice. Front Immunol. 2018;9:1229.","journal-title":"Front Immunol"},{"key":"2426_CR81","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ijbiomac.2022.10.024","volume":"222Pt B","author":"M Meng","year":"2022","unstructured":"Meng M, et al. Lentinan inhibits oxidative stress and alleviates LPS-induced inflammation and apoptosis of BMECs by activating the Nrf2 signaling pathway. Int J Biol Macromol. 2022;222Pt B:2375\u201391.","journal-title":"Int J Biol Macromol"},{"key":"2426_CR82","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.bioorg.2023.106887","volume":"141","author":"H Fang","year":"2023","unstructured":"Fang H, et al. Discovery of new DHA ethanolamine derivatives as potential anti-inflammatory agents targeting Nur77. Bioorg Chem. 2023;141:106887.","journal-title":"Bioorg Chem"},{"issue":"29","key":"2426_CR83","doi-asserted-by":"publisher","first-page":"e2301324","DOI":"10.1002\/adhm.202301324","volume":"12","author":"S Jiang","year":"2023","unstructured":"Jiang S, et al. Black phosphorus as a Targeting PPAR-\u03b3 agonist to reverse Chemoresistance in patient-derived Organoids, mice, and pancreatic tumor cells. Adv Healthc Mater. 2023;12(29):e2301324.","journal-title":"Adv Healthc Mater"},{"key":"2426_CR84","doi-asserted-by":"crossref","unstructured":"Jang WY, Kim MY, Cho JY. Antioxidant, Anti-Inflammatory, Anti-Menopausal, and Anti-Cancer Effects of Lignans and Their Metabolites. Int J Mol Sci, 2022. 23(24).","DOI":"10.3390\/ijms232415482"},{"issue":"17","key":"2426_CR85","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Li Y. CD36 tango in cancer: signaling pathways and functions. Theranostics. 2019;9(17):4893\u2013908.","journal-title":"Theranostics"},{"key":"2426_CR86","doi-asserted-by":"publisher","first-page":"109336","DOI":"10.1016\/j.cellsig.2019.06.001","volume":"62","author":"IH McKillop","year":"2019","unstructured":"McKillop IH, Girardi CA, Thompson KJ. Role of fatty acid binding proteins (FABPs) in cancer development and progression. Cell Signal. 2019;62:109336.","journal-title":"Cell Signal"},{"issue":"4","key":"2426_CR87","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.bbrc.2015.05.108","volume":"463","author":"Y Bian","year":"2015","unstructured":"Bian Y, et al. Up-regulation of fatty acid synthase induced by EGFR\/ERK activation promotes tumor growth in pancreatic cancer. Biochem Biophys Res Commun. 2015;463(4):612\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"2426_CR88","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semcancer.2017.11.020","volume":"54","author":"S Karmakar","year":"2019","unstructured":"Karmakar S, et al. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Semin Cancer Biol. 2019;54:63\u201371.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"2426_CR89","first-page":"6321","volume":"37","author":"E Sokolowska","year":"2017","unstructured":"Sokolowska E, et al. Orlistat reduces proliferation and enhances apoptosis in human pancreatic Cancer cells (PANC-1). Anticancer Res. 2017;37(11):6321\u20137.","journal-title":"Anticancer Res"},{"issue":"1","key":"2426_CR90","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the Wheels of the Cancer machine: the role of lipid metabolism in Cancer. Cell Metab. 2020;31(1):62\u201376.","journal-title":"Cell Metab"},{"issue":"12","key":"2426_CR91","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/pin.13289","volume":"72","author":"Y Wei","year":"2022","unstructured":"Wei Y, et al. Tumor-suppressive miR-323a inhibits pancreatic cancer cell proliferation and glycolysis through targeting HK-2. Pathol Int. 2022;72(12):617\u201330.","journal-title":"Pathol Int"},{"key":"2426_CR92","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2023.05.002","volume":"93","author":"M Lee-Rueckert","year":"2023","unstructured":"Lee-Rueckert M, et al. Obesity-induced changes in cancer cells and their microenvironment: mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. Semin Cancer Biol. 2023;93:36\u201351.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"2426_CR93","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13045-024-01529-6","volume":"17","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, et al. FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion. J Hematol Oncol. 2024;17(1):9.","journal-title":"J Hematol Oncol"},{"key":"2426_CR94","doi-asserted-by":"publisher","first-page":"115501","DOI":"10.1016\/j.biopha.2023.115501","volume":"167","author":"X Ma","year":"2023","unstructured":"Ma X, et al. Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2. Biomed Pharmacother. 2023;167:115501.","journal-title":"Biomed Pharmacother"},{"issue":"7754","key":"2426_CR95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-019-1118-2","volume":"569","author":"F Veglia","year":"2019","unstructured":"Veglia F, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569(7754):73\u20138.","journal-title":"Nature"},{"issue":"2","key":"2426_CR96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser SA, et al. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21(2):147\u201364.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"2426_CR97","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab. 2022;4(12):1660\u201373.","journal-title":"Nat Metab"},{"issue":"2","key":"2426_CR98","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/ijc.33552","volume":"149","author":"M Cao","year":"2021","unstructured":"Cao M, et al. Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through \u03b2-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades. Int J Cancer. 2021;149(2):460\u201372.","journal-title":"Int J Cancer"},{"issue":"30","key":"2426_CR99","doi-asserted-by":"publisher","first-page":"e2211415","DOI":"10.1002\/adma.202211415","volume":"35","author":"C Xu","year":"2023","unstructured":"Xu C, et al. Slimming and reinvigorating Tumor-Associated dendritic cells with hierarchical lipid rewiring nanoparticles. Adv Mater. 2023;35(30):e2211415.","journal-title":"Adv Mater"},{"issue":"8","key":"2426_CR100","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","volume":"33","author":"E Dierge","year":"2021","unstructured":"Dierge E, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021;33(8):1701\u2013e17155.","journal-title":"Cell Metab"},{"issue":"1","key":"2426_CR101","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek SK, et al. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7\u201324.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2426_CR102","doi-asserted-by":"publisher","first-page":"110870","DOI":"10.1016\/j.celrep.2022.110870","volume":"39","author":"YJ Li","year":"2022","unstructured":"Li YJ, et al. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep. 2022;39(9):110870.","journal-title":"Cell Rep"},{"key":"2426_CR103","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molimm.2023.06.004","volume":"160","author":"X Guo","year":"2023","unstructured":"Guo X, et al. CD8\u2009+\u2009T-cell number and function are altered by Shkbp1 knockout mediated suppression of tumor growth in mice. Mol Immunol. 2023;160:32\u201343.","journal-title":"Mol Immunol"},{"issue":"3","key":"2426_CR104","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","volume":"4","author":"Y Fan","year":"2013","unstructured":"Fan Y, Mao R, Yang J. NF-kappaB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4(3):176\u201385.","journal-title":"Protein Cell"},{"issue":"7","key":"2426_CR105","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1002\/jcp.30229","volume":"236","author":"YY Jung","year":"2021","unstructured":"Jung YY, et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway. J Cell Physiol. 2021;236(7):5253\u201364.","journal-title":"J Cell Physiol"},{"issue":"45","key":"2426_CR106","doi-asserted-by":"publisher","first-page":"E6965","DOI":"10.1073\/pnas.1609934113","volume":"113","author":"X Wu","year":"2016","unstructured":"Wu X, et al. FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-kappaB and SP1. Proc Natl Acad Sci U S A. 2016;113(45):E6965\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2426_CR107","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2426_CR108","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","volume":"16","author":"X Luo","year":"2017","unstructured":"Luo X, et al. Emerging roles of lipid metabolism in cancer metastasis. Mol Cancer. 2017;16(1):76.","journal-title":"Mol Cancer"},{"issue":"1","key":"2426_CR109","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1158\/0008-5472.CAN-20-2199","volume":"81","author":"JD Greenlee","year":"2021","unstructured":"Greenlee JD, et al. Rafting down the Metastatic Cascade: the role of lipid rafts in Cancer Metastasis, Cell Death, and clinical outcomes. Cancer Res. 2021;81(1):5\u201317.","journal-title":"Cancer Res"},{"issue":"6","key":"2426_CR110","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","volume":"4","author":"B Paul","year":"2022","unstructured":"Paul B, Lewinska M, Andersen JB. Lipid alterations in chronic liver disease and liver cancer. JHEP Rep. 2022;4(6):100479.","journal-title":"JHEP Rep"},{"issue":"9","key":"2426_CR111","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1002\/ctm2.1045","volume":"12","author":"MH Dalhat","year":"2022","unstructured":"Dalhat MH, et al. NAT10: an RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clin Transl Med. 2022;12(9):e1045.","journal-title":"Clin Transl Med"},{"issue":"13","key":"2426_CR112","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.7150\/thno.55609","volume":"11","author":"KL Zhang","year":"2021","unstructured":"Zhang KL, et al. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer. Theranostics. 2021;11(13):6560\u201372.","journal-title":"Theranostics"},{"issue":"11","key":"2426_CR113","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/0008-5472.CAN-22-3490","volume":"83","author":"CM Deng","year":"2023","unstructured":"Deng CM, et al. ANO1 reprograms cholesterol metabolism and the Tumor Microenvironment to Promote Cancer Metastasis. Cancer Res. 2023;83(11):1851\u201365.","journal-title":"Cancer Res"},{"key":"2426_CR114","doi-asserted-by":"publisher","first-page":"216609","DOI":"10.1016\/j.canlet.2024.216609","volume":"584","author":"X Mei","year":"2024","unstructured":"Mei X, et al. DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4\/PI3K\/AKT axis and VEGF-C secretion. Cancer Lett. 2024;584:216609.","journal-title":"Cancer Lett"},{"issue":"1","key":"2426_CR115","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-021-00276-3","volume":"10","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. MicroRNA-377-3p inhibits hepatocellular carcinoma growth and metastasis through negative regulation of CPT1C-mediated fatty acid oxidation. Cancer Metab. 2022;10(1):2.","journal-title":"Cancer Metab"},{"key":"2426_CR116","doi-asserted-by":"crossref","unstructured":"Schlaepfer IR, Joshi M. CPT1A-mediated Fat Oxidation, mechanisms, and therapeutic potential. Endocrinology, 2020. 161(2).","DOI":"10.1210\/endocr\/bqz046"},{"issue":"4","key":"2426_CR117","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1158\/0008-5472.CAN-22-2156","volume":"83","author":"GC Zhang","year":"2023","unstructured":"Zhang GC, et al. PRP19 enhances esophageal squamous cell Carcinoma Progression by Reprogramming SREBF1-Dependent fatty acid metabolism. Cancer Res. 2023;83(4):521\u201337.","journal-title":"Cancer Res"},{"key":"2426_CR118","doi-asserted-by":"publisher","first-page":"155628","DOI":"10.1016\/j.metabol.2023.155628","volume":"147","author":"T Yang","year":"2023","unstructured":"Yang T, et al. OCTN2 enhances PGC-1alpha-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma. Metabolism. 2023;147:155628.","journal-title":"Metabolism"},{"issue":"5","key":"2426_CR119","doi-asserted-by":"publisher","first-page":"e2200898","DOI":"10.1002\/smtd.202200898","volume":"7","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Blocking cholesterol metabolism with Tumor-Penetrable Nanovesicles to improve Photodynamic Cancer Immunotherapy. Small Methods. 2023;7(5):e2200898.","journal-title":"Small Methods"},{"issue":"9","key":"2426_CR120","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/s41401-020-00572-6","volume":"42","author":"C-j Zhang","year":"2021","unstructured":"Zhang C-j, et al. Celastrol induces lipophagy via the LXR\u03b1\/ABCA1 pathway in clear cell renal cell carcinoma. Acta Pharmacol Sin. 2021;42(9):1472\u201385.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2426_CR121","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12967-023-04236-x","volume":"21","author":"S Ning","year":"2023","unstructured":"Ning S, et al. NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway. J Transl Med. 2023;21(1):362.","journal-title":"J Transl Med"},{"key":"2426_CR122","doi-asserted-by":"crossref","unstructured":"Yang Z et al. Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production. Cell Metab, 2022. 34(12): p. 2018\u20132035.e8.","DOI":"10.1016\/j.cmet.2022.10.010"},{"issue":"11","key":"2426_CR123","doi-asserted-by":"publisher","first-page":"18280","DOI":"10.18632\/oncotarget.15430","volume":"8","author":"T Okumura","year":"2017","unstructured":"Okumura T, et al. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells. Oncotarget. 2017;8(11):18280\u201395.","journal-title":"Oncotarget"},{"issue":"9","key":"2426_CR124","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1021\/acs.jproteome.0c00394","volume":"19","author":"J Liu","year":"2020","unstructured":"Liu J, et al. Cell Metabolomics reveals Berberine-inhibited pancreatic Cancer cell viability and metastasis by regulating citrate metabolism. J Proteome Res. 2020;19(9):3825\u201336.","journal-title":"J Proteome Res"},{"key":"2426_CR125","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2020.02.007","volume":"476","author":"Q Gao","year":"2020","unstructured":"Gao Q, et al. IRE1\u03b1-targeting downregulates ABC transporters and overcomes drug resistance of colon cancer cells. Cancer Lett. 2020;476:67\u201374.","journal-title":"Cancer Lett"},{"issue":"6","key":"2426_CR126","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/mmi.14586","volume":"114","author":"J Song","year":"2020","unstructured":"Song J, Liu X, Li R. Sphingolipids: regulators of azole drug resistance and fungal pathogenicity. Mol Microbiol. 2020;114(6):891\u2013905.","journal-title":"Mol Microbiol"},{"key":"2426_CR127","doi-asserted-by":"publisher","first-page":"34","DOI":"10.33393\/dti.2020.2185","volume":"14","author":"H Tsuchiya","year":"2020","unstructured":"Tsuchiya H, Mizogami M. [Not Available] Drug Target Insights. 2020;14:34\u201347.","journal-title":"[Not Available] Drug Target Insights"},{"issue":"7849","key":"2426_CR128","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim SA, et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature. 2021;591(7849):306\u201311.","journal-title":"Nature"},{"issue":"7459","key":"2426_CR129","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng H, et al. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature. 2013;499(7459):485\u201390.","journal-title":"Nature"},{"issue":"3","key":"2426_CR130","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298\u2013308.","journal-title":"Nat Immunol"},{"key":"2426_CR131","doi-asserted-by":"publisher","first-page":"216235","DOI":"10.1016\/j.canlet.2023.216235","volume":"565","author":"Z Chen","year":"2023","unstructured":"Chen Z, et al. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer. Cancer Lett. 2023;565:216235.","journal-title":"Cancer Lett"},{"issue":"10","key":"2426_CR132","doi-asserted-by":"publisher","first-page":"113126","DOI":"10.1016\/j.celrep.2023.113126","volume":"42","author":"X Li","year":"2023","unstructured":"Li X, et al. NSD2 methylates AROS to promote SIRT1 activation and regulates fatty acid metabolism-mediated cancer radiotherapy. Cell Rep. 2023;42(10):113126.","journal-title":"Cell Rep"},{"issue":"1","key":"2426_CR133","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","volume":"22","author":"X Qiao","year":"2023","unstructured":"Qiao X, et al. Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy. Lipids Health Dis. 2023;22(1):45.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"2426_CR134","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cmet.2020.06.002","volume":"32","author":"X Cheng","year":"2020","unstructured":"Cheng X, et al. Targeting DGAT1 ameliorates glioblastoma by Increasing Fat Catabolism and oxidative stress. Cell Metab. 2020;32(2):229\u2013e2428.","journal-title":"Cell Metab"},{"issue":"7","key":"2426_CR135","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su P, et al. Enhanced lipid Accumulation and Metabolism are required for the differentiation and activation of Tumor-Associated macrophages. Cancer Res. 2020;80(7):1438\u201350.","journal-title":"Cancer Res"},{"issue":"7","key":"2426_CR136","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trecan.2020.03.001","volume":"6","author":"C Attan\u00e9","year":"2020","unstructured":"Attan\u00e9 C, Muller C. Drilling for oil: tumor-surrounding adipocytes fueling Cancer. Trends Cancer. 2020;6(7):593\u2013604.","journal-title":"Trends Cancer"},{"issue":"1","key":"2426_CR137","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer. 2020;19(1):50.","journal-title":"Mol Cancer"},{"issue":"6","key":"2426_CR138","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH. O\u2019Hara, challenges and opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 2020;38(6):788\u2013802.","journal-title":"Cancer Cell"},{"issue":"2","key":"2426_CR139","doi-asserted-by":"publisher","first-page":"C540","DOI":"10.1152\/ajpcell.00331.2022","volume":"324","author":"AK Beutel","year":"2023","unstructured":"Beutel AK, Halbrook CJ. Barriers and opportunities for gemcitabine in pancreatic cancer therapy. Am J Physiol Cell Physiol. 2023;324(2):C540\u201352.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"31","key":"2426_CR140","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/s41388-024-03092-3","volume":"43","author":"MJ Ma","year":"2024","unstructured":"Ma MJ, et al. N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance. Oncogene. 2024;43(31):2405\u201320.","journal-title":"Oncogene"},{"key":"2426_CR141","doi-asserted-by":"crossref","unstructured":"Rebelo A, Kleeff J, Sunami Y. Cholesterol Metabolism Pancreat Cancer Cancers (Basel), 2023. 15(21).","DOI":"10.3390\/cancers15215177"},{"issue":"10","key":"2426_CR142","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","volume":"56","author":"LA Broadfield","year":"2021","unstructured":"Broadfield LA, et al. Lipid metabolism in cancer: new perspectives and emerging mechanisms. Dev Cell. 2021;56(10):1363\u201393.","journal-title":"Dev Cell"},{"issue":"3","key":"2426_CR143","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cmet.2020.07.008","volume":"32","author":"I Hamaidi","year":"2020","unstructured":"Hamaidi I, et al. Sirt2 inhibition enhances metabolic fitness and effector functions of Tumor-reactive T cells. Cell Metab. 2020;32(3):420\u2013e43612.","journal-title":"Cell Metab"},{"key":"2426_CR144","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen C, et al. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front Immunol. 2023;14:1133308.","journal-title":"Front Immunol"},{"issue":"1","key":"2426_CR145","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12964-023-01178-1","volume":"21","author":"D Zipinotti Dos Santos","year":"2023","unstructured":"Zipinotti Dos Santos D, et al. The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. Cell Commun Signal. 2023;21(1):161.","journal-title":"Cell Commun Signal"},{"key":"2426_CR146","doi-asserted-by":"crossref","unstructured":"Shi B et al. Variation in the fatty acid synthase gene (FASN) and its association with milk traits in Gannan Yaks. Anim (Basel), 2019. 9(9).","DOI":"10.3390\/ani9090613"},{"issue":"6","key":"2426_CR147","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1242\/dmm.011338","volume":"6","author":"F Baenke","year":"2013","unstructured":"Baenke F, et al. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech. 2013;6(6):1353\u201363.","journal-title":"Dis Model Mech"},{"issue":"4","key":"2426_CR148","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10911-021-09505-3","volume":"26","author":"AV Ward","year":"2021","unstructured":"Ward AV, Anderson SM, Sartorius CA. Advances in analyzing the breast Cancer Lipidome and its relevance to Disease Progression and Treatment. J Mammary Gland Biol Neoplasia. 2021;26(4):399\u2013417.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"10","key":"2426_CR149","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","volume":"27","author":"RA Calle","year":"2021","unstructured":"Calle RA, et al. ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat Med. 2021;27(10):1836\u201348.","journal-title":"Nat Med"},{"issue":"3","key":"2426_CR150","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1142\/S0192415X23500362","volume":"51","author":"L Hu","year":"2023","unstructured":"Hu L, et al. Epigallocatechin-3-Gallate decreases Hypoxia-Inducible Factor-1 in pancreatic Cancer cells. Am J Chin Med. 2023;51(3):761\u201377.","journal-title":"Am J Chin Med"},{"issue":"3","key":"2426_CR151","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/14740338.2020.1715939","volume":"19","author":"N Alkhushaym","year":"2020","unstructured":"Alkhushaym N, et al. Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis. Expert Opin Drug Saf. 2020;19(3):327\u201334.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"2426_CR152","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1248\/bpb.b19-00435","volume":"43","author":"T Kawashiri","year":"2020","unstructured":"Kawashiri T, et al. Anti-tumor activities of 3-Hydroxy-3-methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitors and bisphosphonates in pancreatic cell lines which show poor responses to Gemcitabine. Biol Pharm Bull. 2020;43(1):49\u201352.","journal-title":"Biol Pharm Bull"},{"key":"2426_CR153","doi-asserted-by":"crossref","unstructured":"Wei R et al. Epigallocatechin-3-Gallate (EGCG) suppresses pancreatic Cancer Cell Growth, Invasion, and Migration partly through the inhibition of Akt Pathway and epithelial-mesenchymal transition: enhanced efficacy when combined with Gemcitabine. Nutrients, 2019. 11(8).","DOI":"10.3390\/nu11081856"},{"key":"2426_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.03.026","volume":"509","author":"CJ Wang","year":"2021","unstructured":"Wang CJ, et al. Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase. Cancer Lett. 2021;509:1\u201312.","journal-title":"Cancer Lett"},{"issue":"2","key":"2426_CR155","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MPA.0000000000001737","volume":"50","author":"K Skrypek","year":"2021","unstructured":"Skrypek K, et al. Inhibition of Stearoyl-CoA desaturase induces the unfolded protein response in pancreatic tumors and suppresses their growth. Pancreas. 2021;50(2):219\u201326.","journal-title":"Pancreas"},{"issue":"3","key":"2426_CR156","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1021\/nn504025a","volume":"9","author":"SS Lee","year":"2015","unstructured":"Lee SS, et al. Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment. ACS Nano. 2015;9(3):2420\u201332.","journal-title":"ACS Nano"},{"key":"2426_CR157","doi-asserted-by":"crossref","unstructured":"Rochette L et al. Lipid peroxidation and Iron metabolism: two Corner stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci, 2022. 24(1).","DOI":"10.3390\/ijms24010449"},{"issue":"9","key":"2426_CR158","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.21873\/anticanres.11016","volume":"36","author":"K Nishi","year":"2016","unstructured":"Nishi K, et al. Inhibition of fatty acid synthesis induces apoptosis of human pancreatic Cancer cells. Anticancer Res. 2016;36(9):4655\u201360.","journal-title":"Anticancer Res"},{"key":"2426_CR159","doi-asserted-by":"crossref","unstructured":"Yun, S.-W., et al., Lactobacillus gasseri NK109 and Its Supplement Alleviate Cognitive Impairment in Mice by Modulating NF-\u03baB Activation, BDNF Expression, and Gut Microbiota Composition. Nutrients, 2023. 15(3): p. 790.","DOI":"10.3390\/nu15030790"},{"key":"2426_CR160","doi-asserted-by":"publisher","first-page":"216307","DOI":"10.1016\/j.canlet.2023.216307","volume":"570","author":"Y Qin","year":"2023","unstructured":"Qin Y, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570:216307.","journal-title":"Cancer Lett"},{"key":"2426_CR161","doi-asserted-by":"publisher","first-page":"106822","DOI":"10.1016\/j.phrs.2023.106822","volume":"194","author":"M Ashrafizadeh","year":"2023","unstructured":"Ashrafizadeh M, et al. A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: complexity and simplicity in crosstalk. Pharmacol Res. 2023;194:106822.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2426_CR162","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jss.2009.04.022","volume":"165","author":"MJ Strouch","year":"2011","unstructured":"Strouch MJ, et al. A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res. 2011;165(1):75\u201381.","journal-title":"J Surg Res"},{"issue":"1","key":"2426_CR163","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12935-023-03138-8","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells. Cancer Cell Int. 2023;23(1):276.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"2426_CR164","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1158\/1541-7786.MCR-22-0602","volume":"21","author":"N McBrearty","year":"2023","unstructured":"McBrearty N, et al. Tumor-suppressive and Immune-stimulating roles of cholesterol 25-hydroxylase in pancreatic Cancer cells. Mol Cancer Res. 2023;21(3):228\u201339.","journal-title":"Mol Cancer Res"},{"key":"2426_CR165","doi-asserted-by":"crossref","unstructured":"Oberle R et al. The HDL particle composition determines its antitumor activity in pancreatic cancer. Life Sci Alliance, 2022. 5(9).","DOI":"10.26508\/lsa.202101317"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-024-02426-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-024-02426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:08:48Z","timestamp":1736780928000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-024-02426-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":165,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2426"],"URL":"https:\/\/doi.org\/10.1186\/s12944-024-02426-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical Approval is not required for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"12"}}